Progress of Research on Advanced Non-Small Cell Lung Cancer with HER-2 Mutation

Progress of Research on Advanced Non-Small Cell Lung Cancer with HER-2 Mutation

Anti-tumor drug research and development in non-small cell lung cancer (NSCLC) is rapidly developing, and the clinical application of high-throughput sequencing technology is also becoming widespread. Accordingly, researchers are focusing on human epidermal growth factor receptor-2 (HER-2) gene as a...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang ZHANG, Changliang YANG, Peidong LI, Ying CHENG
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2025-02-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
non-small cell lung cancer
her-2 mutation
antibody drug conjugate
her-2 inhibitors
Online Access:http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2025.24.1062
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items